Kestra Private Wealth Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Sell |
3,834
-13,637
| -78% | -$1.13M | ﹤0.01% | 1247 |
|
|
2025
Q1 | $1.42M | Sell |
17,471
-614
| -3% | -$49.8K | 0.02% | 555 |
|
|
2024
Q4 | $1.63M | Sell |
18,085
-600
| -3% | -$54K | 0.03% | 491 |
|
|
2024
Q3 | $1.85M | Sell |
18,685
-97
| -0.5% | -$9.58K | 0.03% | 446 |
|
|
2024
Q2 | $1.74M | Sell |
18,782
-700
| -4% | -$64.9K | 0.03% | 425 |
|
|
2024
Q1 | $1.85M | Buy |
19,482
+475
| +2% | +$45.1K | 0.04% | 396 |
|
|
2023
Q4 | $1.7M | Buy |
19,007
+14,453
| +317% | +$1.29M | 0.04% | 387 |
|
|
2023
Q3 | $333K | Buy |
4,554
+574
| +14% | +$41.9K | 0.01% | 822 |
|
|
2023
Q2 | $331K | Buy |
3,980
+260
| +7% | +$21.6K | 0.01% | 783 |
|
|
2023
Q1 | $284K | Buy |
3,720
+108
| +3% | +$8.23K | 0.01% | 802 |
|
|
2022
Q4 | $300K | Sell |
3,612
-466
| -11% | -$38.7K | 0.02% | 673 |
|
|
2022
Q3 | $323K | Buy |
4,078
+333
| +9% | +$26.4K | 0.02% | 624 |
|
|
2022
Q2 | $278K | Sell |
3,745
-758
| -17% | -$56.3K | 0.02% | 680 |
|
|
2022
Q1 | $405K | Buy |
4,503
+1,822
| +68% | +$164K | 0.02% | 646 |
|
|
2021
Q4 | $300K | Buy |
2,681
+261
| +11% | +$29.2K | 0.01% | 762 |
|
|
2021
Q3 | $304K | Sell |
2,420
-4,250
| -64% | -$534K | 0.02% | 702 |
|
|
2021
Q2 | $903K | Sell |
6,670
-8
| -0.1% | -$1.08K | 0.05% | 355 |
|
|
2021
Q1 | $906K | Sell |
6,678
-634
| -9% | -$86K | 0.06% | 312 |
|
|
2020
Q4 | $1.05M | Sell |
7,312
-1,149
| -14% | -$166K | 0.08% | 256 |
|
|
2020
Q3 | $934K | Buy |
+8,461
| New | +$934K | 0.08% | 252 |
|